HOME     |     CONTACT


Search  

EastGen News

BOVITEQ ANNOUNCES NEW LICENSEE IN THE NETHERLANDS
Boviteq is pleased to announce that Diamond Genetics in the Netherlands will serve as our In Vitro ...
JDS Article Proves Immunity+® Cows More Resilient To Bird Flu
We're excited to announce that an article by Semex's Dr. Shannon Beard, Mark Carson, Dr. Mi...
SEMEX ANNOUNCES NEW SUBSIDIARY IN HOLLAND
Semex Is Pleased To Announce The Purchase of Semex Holland From Bles Dairies The Semex Board ...
SEMEX ANNOUNCES JON SCHEFERS NAMED US GENERAL MANAGER
Semex Is Pleased To Announce The Appointment of Jon Schefers as the US General Manager, Effectiv...
NEOGEN® AND SEMEX® PARTNER TO DELIVER SEMEX’S IMMUNITY TECHNOLOGY FOR HEALTHIER HERDS
Neogen Corporation and Semex announced today their partnership to deliver Semex’s Immunity Te...
SEMEX ANNOUNCES RYAN LETT SUCCEEDS DAVID MAYO AT SEMEX NEW ZEALAND
Semex is pleased to announce that Ryan Lett will succeed David Mayo as General Manager of Semex N...

Leggi Tutti gli Articoli
Impressive Repromax® Results In Brazil
Articolo postato su Febbraio 29, 2012, 15:33:25

Dairymen worldwide need all the tools available to ensure reproductive efficiency in their herds during warmer months and year round.

Semex's Repromaxâ"¢ brand quickly identifies those Semex sires with above average semen fertility, and leading conception rates. Recent research results from field studies in Brazil clearly show the advantages of Repromaxâ"¢ for conception rates in herds with reproductive challenges. The following study was carried out on nine dairy farms in the counties of Castro and Carambeí, State of Parana, Brazil, where high milk yields contribute to even greater reproductive challenges. The results speak for themselves:

none These impressive results only prove the seriousness, quality control and success of Semex semen and Repromaxâ"¢. Do not miss the opportunity of using Repromaxâ"¢ in your breeding program! For more information on Semex's Repromaxâ"¢ line-up click here.



Stampa questo Articolo | Invia questo Articolo